Photo: Tanja Ivanova/Getty Images
Calm Health, a clinical mental health platform powered by meditation app Calm, is partnering with LifeStance Health to guide its users with higher-acuity mental healthcare needs to a hybrid behavioral health specialist.
LifeStance Health offers psychiatry for adults and children, therapy services, psychiatric medication management, neuropsychological testing and evaluation, psychological testing and evaluation, and specialty treatments.
Calm Health works with employers and health plans to offer support for mental and physical conditions, including mental health screenings to identify the symptoms and severity of anxiety and depression.
Through the partnership, Calm Health users in need of high-acuity treatment can be guided to LifeStance through the Calm Health app.
Calm Health users will complete a mental health screening and onboarding questionnaire and, based on the results, will be recommended a personalized plan that can range from mindfulness to digital clinical programs for specific conditions.
A referral to LifeStance will now be an option for Calm Health users who are determined to require more direct clinical care.
"Even with more mental health resources available than ever, people are still left to navigate a confusing and crowded landscape on their own," Chris Carey, SVP and general manager of Calm Health, said in a statement.
"At Calm, our mission is to support people at every step of their mental health journey, including helping them find trusted resources faster, removing barriers to care and ultimately driving positive health outcomes. Adding LifeStance as a trusted mental health care resource helps us deliver on this mission by connecting members to high-quality care more quickly and confidently."
THE LARGER TREND
Calm Health, which launched in 2022, expanded internationally in June. The privately held company announced its plans to offer virtual mental health support with its initial rollout in the UK and Canada.
As of this week, the company is available globally with language support across 10 languages, including English, Spanish, French, German, Korean, Polish, Portuguese, Japanese, Italian and Mandarin.
The Palo Alto, California-based company said the expansion allows multinational employers to offer more comprehensive mental health services.
In January, Calm Health partnered with Magellan Health, which offers behavioral health and employee assistance programs to its members. The partnership allows Calm Health to be accessible to Magellan employer customers and their members.
Meanwhile, publicly traded LifeStance Health [NASDAQ: LFST] is expected to release its Q3 2025 earnings on Nov. 6.
Its Q2 2025 earnings showed revenue of $345.3 million, an 11% increase compared to $312.3 million in the same period last year, and a net loss of $3.8 million in the second quarter compared to a loss of $23.3 million in Q2 2024.
Net cash provided by operations was $64.4 million in the second quarter of the year, and adjusted EBITDA was reported as $34 million, a 19% increase compared to adjusted EBITDA of $28.6 million in Q2 2024.
The company expects full-year revenue of $1.4 billion to $1.44 billion and adjusted EBITDA of $140 million to $150 million.
LifeStance Health's stock is currently trading at $4.94 per share.
